578 related articles for article (PubMed ID: 32181685)
1. Efficacy of the Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis.
Tabriz NS; Skak K; Kassayeva LT; Omarkulov BK; Grigolashvili MA
Microb Drug Resist; 2020 Aug; 26(8):997-1004. PubMed ID: 32181685
[No Abstract] [Full Text] [Related]
2. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L
Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619
[TBL] [Abstract][Full Text] [Related]
3. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
[TBL] [Abstract][Full Text] [Related]
4. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
[TBL] [Abstract][Full Text] [Related]
5. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
Mboowa G; Namaganda C; Ssengooba W
BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice.
Kwak N; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
PLoS One; 2013; 8(10):e77456. PubMed ID: 24204834
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
9. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
Rice JP; Seifert M; Moser KS; Rodwell TC
PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
[TBL] [Abstract][Full Text] [Related]
10. Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis.
Bai W; Liu L; Wu L; Chen S; Wu S; Wang Z; Xu K; Chi Q; Pan Y; Xu X
J Clin Lab Anal; 2022 Jan; 36(1):e24154. PubMed ID: 34850984
[TBL] [Abstract][Full Text] [Related]
11. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
[TBL] [Abstract][Full Text] [Related]
12. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
[TBL] [Abstract][Full Text] [Related]
14. The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa's Eastern Cape Province.
Iruedo J; O'Mahony D; Mabunda S; Wright G; Cawe B
BMC Infect Dis; 2017 Jan; 17(1):91. PubMed ID: 28109255
[TBL] [Abstract][Full Text] [Related]
15. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
[TBL] [Abstract][Full Text] [Related]
16. [Comparing performance of "TB-BIOCHIP", "Xpert MTB/RIF" and "genotype MTBDRplus" assays for fast identification of mutations in the Mycobacterium tuberculosis complex in sputum from TB patients].
Nosova EIu; Krasnova MA; Galkina KIu; Makarova MV; Litvinov VI; Moroz AM
Mol Biol (Mosk); 2013; 47(2):267-74. PubMed ID: 23808160
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
[TBL] [Abstract][Full Text] [Related]
18. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients.
Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB
Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390
[TBL] [Abstract][Full Text] [Related]
19. Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF.
Soedarsono S; Mertaniasih NM; Hasan H; Kusmiati T; Permatasari A; Kusumaningrum D; Wijaksono W
Int J Mycobacteriol; 2022; 11(4):429-434. PubMed ID: 36510930
[TBL] [Abstract][Full Text] [Related]
20. GeneXpert
Christopher PM; ; Widysanto A
Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
